The -1021C→T DBH gene variant is not associated with epilepsy or antiepileptic drug response

Neurology

Volumn 63, Issue 8, 2004, Pages 1497-1499

  Depondt, C ^a   Cock, H R ^b   Healy, D G ^a   Burley, M W ^a   Weinshenker, D ^c   Wood, N W ^a   Goldstein, D B ^a   Sisodiya, S M ^b,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; NORADRENALIN;

ADULT; ARTICLE; CONTROLLED STUDY; DBH GENE; DOPAMINE METABOLISM; DRUG RESPONSE; EPILEPSY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; BIOSYNTHESIS; COHORT ANALYSIS; DRUG RESISTANCE; EUROPE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; POINT MUTATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTICONVULSANTS; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; DOPAMINE BETA-HYDROXYLASE; DRUG RESISTANCE; EPILEPSY; EUROPE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; NOREPINEPHRINE; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; VARIATION (GENETICS);

EID: 7044250890     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000142092.16719.AD     Document Type: Article

References (10)

1. Weinshenker D, Szot P. The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol Ther 2002;94:213-233.
2. Szot P, Weinshenker D, White SS, et al. Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli. J Neurosci 1999;19:10985-10992.
3. Szot P, Weinshenker D, Rho JM, Storey TW, Schwartzkroin PA. Norepinephrine is required for the anticonvulsant effect of the ketogenic diet. Brain Res Dev Brain Res 2001;129:211-214.
4. Healy DG, Abou-Sleiman PM, Ozawa T, et al. A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease. Ann Neurol 2004;55:443-446.
5. Warter JM, Coquillat G, Kurtz D. Human circulating dopamine-beta- hydroxylase and epilepsy. Psychopharmacologia 1975;41:75-79.
6. Zabetian CP, Anderson GM, Buxbaum SG, et al. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 2001;68:515-522.
7. Zabetian CP, Buxbaum SG, Elston RC, et al. The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity. Am J Hum Genet 2003;72:1389-1400.
8. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989;30:389-399.
9. Sisodiya SM. Mechanisms of antiepileptic drug resistance. Curr Opin Neurol 2003;16:197-201.
10. Purcell S. CSSPC, Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-150.